切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Deubiquitinating enzymes (DUBs) - Acetylcholine - Hec1 - P-glycoprotein (P-gp) - Calcium-Activated Potassium (KCa) Channels

16件产品中的 1-10

页面
每页
清除全部
  1. Spautin-1
    B5873 Spautin-1
     1 Citation
    Target: Deubiquitinating enzymes (DUBs)|Autophagy
    Summary: 自噬抑制剂
      ≥13.5 mg/mL
      insoluble in H2O
  2. TAI-1
    B4892 TAI-1
    Target: Hec1
    Summary: Hec1抑制剂
      ≥43.2 mg/mL
      insoluble in H2O
  3. Cisatracurium Besylate
    B1355 Cisatracurium Besylate
    中文名: 顺苯磺阿曲库铵
    Target: Acetylcholine
    Summary: 神经肌肉阻滞药
      ≥62.17 mg/mL
      ≥24.7 mg/mL
  4. Dequalinium Chloride
    B2191 Dequalinium Chloride
    中文名: 地喹氯铵
    Target: PKC|Calcium-Activated Potassium (KCa) Channels
    Summary: PKC抑制剂
      insoluble in DMSO
      insoluble in H2O
  5. ML-323
    B1317 ML-323
    Target: Deubiquitinating enzymes (DUBs)
    Summary: USP1-UAF1抑制剂
      ≥15.05 mg/mL
      ≥2.25 mg/mL
  6. LY335979 (Zosuquidar 3HCL)
    A8549 LY335979 (Zosuquidar 3HCL)
     1 Citation
    中文名: 唑喹达三盐酸盐
    Target: P-glycoprotein (P-gp)
    Summary: Pgb(P糖蛋白)抑制剂
      ≥17.1 mg/mL
      ≥31.9 mg/mL
  7. Zonisamide
    A5354 Zonisamide
    中文名: 唑尼沙胺
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) Channels
    Summary: 抗惊厥和机械效应的抗癫痫药
      ≥8.35 mg/mL
      insoluble in H2O
  8. TRAM-34
    A1888 TRAM-34
    Target: Calcium-Activated Potassium (KCa) Channels
    Summary: KCa3.1阻断剂
      ≥17.25 mg/mL
      insoluble in H2O
  9. PR-619
    A8212 PR-619
    Target: Deubiquitinating enzymes (DUBs)
    Summary: 去泛素化酶(DUBs)抑制剂
      ≥11.15 mg/mL
      insoluble in H2O
  10. NSC 687852 (b-AP15)
    A4453 NSC 687852 (b-AP15)
    Target: Deubiquitinating enzymes (DUBs)
    Summary: 19S调节颗粒抑制剂
      ≥20.95 mg/mL
      insoluble in H2O

16件产品中的 1-10

页面
每页